Literature DB >> 15829633

Receptor tyrosine phosphatases guide vertebrate motor axons during development.

Laurie Stepanek1, Andrew W Stoker, Esther Stoeckli, John L Bixby.   

Abstract

Receptor-type protein tyrosine phosphatases (RPTPs) are required for appropriate growth of axons during nervous system development in Drosophila. In the vertebrate, type IIa RPTPs [protein tyrosine phosphatase (PTP)-delta, PTP-sigma, and LAR (leukocyte common-antigen-related)] and the type III RPTP, PTP receptor type O (PTPRO), have been implicated in the regulation of axon growth, but their roles in developmental axon guidance are unclear. PTPRO, PTP-delta, and PTP-sigma are each expressed in chick motor neurons during the period of axonogenesis. To examine potential roles of RPTPs in axon growth and guidance in vivo, we used double-stranded RNA (dsRNA) interference combined with in ovo electroporation to knock down RPTP expression levels in the embryonic chick lumbar spinal cord. Although most branches of the developing limb nerves appeared grossly normal, a dorsal nerve identified as the anterior iliotibialis was clearly affected by dsRNA knock-down of RPTPs. In experimental embryos treated with dsRNA targeting PTP-delta, PTP-sigma, or PTPRO, this nerve showed abnormal fasciculation, was reduced in size, or was missing entirely; interference with PTPRO produced the most severe phenotypes. Control embryos electroporated with vehicle, or with dsRNA targeting choline acetyltransferase or axonin-1, did not exhibit this phenotype. Surprisingly, embryos electroporated with dsRNA targeting PTP-delta together with PTPRO, or all three RPTPs combined, had less severe phenotypes than embryos treated with PTPRO alone. This result suggests that competition between type IIa and type III RPTPs can regulate motor axon outgrowth, consistent with findings in Drosophila. Our results indicate that RPTPs, and especially PTPRO, are required for axon growth and guidance in the developing vertebrate limb.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15829633      PMCID: PMC6724933          DOI: 10.1523/JNEUROSCI.4531-04.2005

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  41 in total

1.  Tyrosine phosphatases epsilon and alpha perform specific and overlapping functions in regulation of voltage-gated potassium channels in Schwann cells.

Authors:  Zohar Tiran; Asher Peretz; Tal Sines; Vera Shinder; Jan Sap; Bernard Attali; Ari Elson
Journal:  Mol Biol Cell       Date:  2006-07-26       Impact factor: 4.138

2.  Differential activities in adhesion and neurite growth of fibronectin type III repeats in the PTP-delta extracellular domain.

Authors:  Manuel R Gonzalez-Brito; John L Bixby
Journal:  Int J Dev Neurosci       Date:  2006-10-10       Impact factor: 2.457

Review 3.  Receptor protein tyrosine phosphatase from stem cells to mature glial cells of the central nervous system.

Authors:  Smaragda Lamprianou; Sheila Harroch
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

4.  Transient expression of LIM-domain transcription factors is coincident with delayed maturation of photoreceptors in the chicken retina.

Authors:  Andy J Fischer; Shane Foster; Melissa A Scott; Patrick Sherwood
Journal:  J Comp Neurol       Date:  2008-02-01       Impact factor: 3.215

5.  Dimerization of protein tyrosine phosphatase sigma governs both ligand binding and isoform specificity.

Authors:  Simon Lee; Clare Faux; Jennifer Nixon; Daniel Alete; John Chilton; Muhamed Hawadle; Andrew W Stoker
Journal:  Mol Cell Biol       Date:  2006-12-18       Impact factor: 4.272

6.  Identification of Dlk1, Ptpru and Klhl1 as novel Nurr1 target genes in meso-diencephalic dopamine neurons.

Authors:  Frank M J Jacobs; Annemarie J A van der Linden; Yuhui Wang; Lars von Oerthel; Hei Sook Sul; J Peter H Burbach; Marten P Smidt
Journal:  Development       Date:  2009-06-10       Impact factor: 6.868

7.  GLEPP1/protein-tyrosine phosphatase phi inhibitors block chemotaxis in vitro and in vivo and improve murine ulcerative colitis.

Authors:  Rosanna Pescini Gobert; Monique van den Eijnden; Cedric Szyndralewiez; Catherine Jorand-Lebrun; Dominique Swinnen; Linfeng Chen; Corine Gillieron; Fiona Pixley; Pierre Juillard; Patrick Gerber; Caroline Johnson-Léger; Serge Halazy; Montserrat Camps; Agnes Bombrun; Margaret Shipp; Pierre-Alain Vitte; Vittoria Ardissone; Chiara Ferrandi; Dominique Perrin; Christian Rommel; Rob Hooft van Huijsduijnen
Journal:  J Biol Chem       Date:  2009-02-20       Impact factor: 5.157

Review 8.  PTPRD: neurobiology, genetics, and initial pharmacology of a pleiotropic contributor to brain phenotypes.

Authors:  George R Uhl; Maria J Martinez
Journal:  Ann N Y Acad Sci       Date:  2019-01-15       Impact factor: 5.691

9.  Kinase/phosphatase overexpression reveals pathways regulating hippocampal neuron morphology.

Authors:  William J Buchser; Tatiana I Slepak; Omar Gutierrez-Arenas; John L Bixby; Vance P Lemmon
Journal:  Mol Syst Biol       Date:  2010-07       Impact factor: 11.429

10.  In ovo RNAi opens new possibilities for temporal and spatial control of gene silencing during development of the vertebrate nervous system.

Authors:  Thomas Baeriswyl; Esther T Stoeckli
Journal:  J RNAi Gene Silencing       Date:  2006-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.